The AHSN Network has supported many innovators to help advance our health and care system. Find out more about successful innovations supported by the NHS.
Find your nearest AHSN
Active+me is a solution developed by Aseptika which empowers patients to take charge of their own recovery, providing them with standard cardiac rehabilitation care which includes guidance on safe exercise and education on risk factors and lifestyle changes, reinforced by educational resources on the Active+me platform. In addition, patients are provided with medical monitors to take home and record progress such as activity levels, blood pressure, weight and oxygen saturation. The data from which are uploaded to an app and shared securely with the hospital’s cardiac rehabilitation team. In response to the Coronavirus pandemic, Aseptika adapted the programme to help patients keep up their exercise remotely and manage their recovery thanks to funding from Innovate UK and support from Eastern AHSN. Active+me REMOTE
CamAPS FX is an artificial pancreas app which aims to help manage glucose levels in people with type 1 diabetes, aged one year and older, using a hybrid closed-loop approach. The user has the option of easing off or boosting therapy as physiological demands require, such as during exercise. The app runs on a standard Android smartphone and feeds data to the cloud so that health care professionals and loved ones including parents can see their children’s levels at any time on their phones. Developed by CamDiab at the University of Cambridge trials have shown a significant increase in glucose time in range and improved quality of life, as well as a reduction in time spent in hypoglycaemia and hyperglycaemia. An Eastern AHSN commissioned health economic assessment also demonstrated a potential cost saving of £3.2m per year for healthcare in the UK. We are now supporting the roll out of this innovation across the NHS. Visit the CamDiab website now.
Cambridge Respiratory Innovations (Camresp)
Camresp have developed a CE-marked, proprietary, CO2 sensing device named N-Tidal, which enables them to collect more data from normal breathing than ever before. The device provides new insights into lung function. The connected hand-held device is simple to use, requires little-to-no training and is perfect for use within the clinic or at home. It is suitable for patients as young as 4 years old as well as the elderly. With unique insights, as well as correlations to FEV1, PEF and FEV25-75, the N-Tidal brings a new paradigm in the diagnosis, monitoring and management of cardiorespiratory conditions.
Beringar has developed ground-breaking new technology that provides a comprehensive digital picture of how NHS buildings are being utilised. The system detects both human activity and equipment (location and movement). It also monitors eight different environmental factors to support better human-building interaction.
The Digital Pioneer programme has helped to implement secure video communication to connect paramedics with local specialist stroke consultants from their ambulance.
Eastern AHSN and West Suffolk NHS Foundation Trust have been trailing Medic Bleep, a communication tool, to improve service efficiency and reducing delays in sharing patient information between clinicians, staff and outpatient departments.
Eastern AHSN is working with NHS England (Midlands and East) and Healios to implement online CBT for children and young people in contact with the criminal justice system.
Stay Alive app
Eastern AHSN is supporting the evaluation of the Stay Alive app which is a suicide prevention resource for the UK, packed full of useful information and tools to help you stay safe in crisis.
Improving the systems available during a mental health crisis can support staff and patients during a very difficult time of care. S12 Solutions is an app designed to reduce the time spent bringing the right team together for a Mental Health Act assessment.